1. European Medicines Agency. Committee for Medicinal Products for Human Use (CHMP). Guideline on Bioanalytical Method Validation. London, UK (2011). EMEA/CHMP/EWP/192217/2009. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-bioanalytical-method-validation_en.pdf
2. US Department of Health and Human Services, US FDA, Center for Drug Evaluation and Research, Center for Veterinary Medicine. Guidance for Industry, Bioanalytical Method Validation. Rockville, MD, USA (2018).
3. ICH M10, Draft Bioanalytical Method Validation (February 2019). https://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Multidisciplinary/M10/M10EWG_Step2_DraftGuideline_2019_0226.pdf
4. US Department of Health and Human Services, US FDA, Center for Drug Evaluation and Research, Center for Biologics Evaluation and Research. Draft Guidance for industry. Biomarker Qualification: Evidentiary Framework. Rockville, MD, USA (2018). https://www.fda.gov/media/122319/download
5. Guideline on Immunogenicity assessment of therapeutic proteins, EMA 2016. https://www.ema.europa.eu/en/documents/scientific-guideline/guideline-immunogenicity-assessment-therapeutic-proteins-revision-1_en.pdf